Canadian Trademark Information

On Monday, February 8, 2016, a canadian trademark registration was filed for the above pictured logo by STERIMAX INC. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1767163. The current status of this trademark filing is Registration published. The correspondent listed for is GEORGE D. CROSSMAN of *********, **********, ***** **** The trademark is filed in the description of Development, production, marketing and distribution of hospital and retail pharmacy products. , Pharmacy products including injectables, oral solids and topicals. , Pharmaceutical products namely vitamin, diuretic, antibiotic, anaesthetic, anti-hypertensive injectables and anticonvulsant, analgesic, antifibrinolytic injectables for the treatment of bacterial infections, pain and inflammation, cancer, cadiovascular diseases, neurological diseases, trauma, poisoning, and vitamin or enzyme deficiencies, and corticosteroid injectables; antifungal adn anti-inflammatory topical preparations; oral tablets for the treatment of lactose intolerance, muscle relaxant and anti-leukemic tablets; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of allergies. , Specializing in developing, producing, database marketing, namely marketing analysis in the form of consulting, designing, printing and collecting marketing information to identify the unmet needs of the Canadian healthcare market and compiling customer specific databases for marketing purposes, and distributing essential hospital and retail generic and branded pharmaceutical products to the Canadian heatlhcare market namely sterile injectable products, namely anti-hypertensive injectables and antifibrinolytic injectables for the treatment of bacterial infections, pain and inflammation, cancer, cardiovascular diseases, neurological diseases, trauma, poisoning, and vitamin or enzyme deficiencies, and cortisocertoid injectables, retail of oral solids, namely oral tablets for teh treatment of lactose intolerance and anti-leukemic tablets, and nasal spray products that are predominantly available through retail pharmacy outlets. .